Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04066296 · ClinicalTrials.gov registry record · Phase 2

Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

A Phase 2 study of Lumbar Spinal Stenosis, sponsored by University of Colorado, Denver.

Recruiting
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT04066296 is a Phase 2 study of Lumbar Spinal Stenosis that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 100 participants, below the 664-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04066296, a Phase 2 study of Lumbar Spinal Stenosis, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

Conditions Studied

Lumbar Spinal Stenosis

Interventions

  • DRUG Liposomal bupivacaine

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-09-08
Est. Completion 2025-01
Phase Phase 2

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04066296

The ClinicalTrials.gov registry entry for NCT04066296 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 664-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (85% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lumbar Spinal Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Liposomal bupivacaine is the first listed.

NCT04066296 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04066296 about?

NCT04066296 is a clinical study titled "Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine". Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

What is the current status of trial NCT04066296?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2019-09-08. Estimated completion is 2025-01.

What conditions does trial NCT04066296 study?

This clinical trial studies the following conditions: Lumbar Spinal Stenosis.

What interventions are being tested in trial NCT04066296?

The interventions under investigation include: Liposomal bupivacaine (DRUG).

Who is sponsoring clinical trial NCT04066296?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04066296 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lumbar Spinal Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lumbar Spinal Stenosis

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.